Nonlinear relationship between mycophenolate mofetil dose and mycophenolic acid exposure: Implications for therapeutic drug monitoring
(Article)
Winter, B.C.M. de Mathot, R.A.A. Sombogaard, F. Vulto, A.G. Gelder, T. van
|
2011-03-01
|
Differences in clearance of mycophenolic acid among renal transplant recipients, hematopoietic stem cell transplant recipients, and patients with autoimmune disease
(Article)
Winter, B.C.M. de Mathot, R.A.A. Sombogaard, F. Neumann, I. Hest, R.M. van Doorduijn, J.K. Gelder, T. van
|
2010-10-01
|
Pharmacodynamic Monitoring of Inosine Monophosphate Dehydrogenase Activity: A Basis For Optimized and Individualized Mycophenolate Mofetil Therapy
(Doctoral Thesis)
Sombogaard, F.
|
2010-03-12
|
Pharmacokinetic role of protein binding of mycophenolic acid and its glucuronide metabolite in renal transplant recipients
(Article)
Winter, B.C.M. de Gelder, T. van Sombogaard, F. Shaw, L.M. Hest, R.M. van Mathot, R.A.
|
2009-12-01
|
Inosine monophosphate dehydrogenase messenger RNA expression is correlated to clinical outcomes in mycophenolate mofetil-treated kidney transplant patients, whereas inosine monophosphate dehydrogenase activity is not
(Article)
Sombogaard, F. Peeters, A.M.A. Baan, C.C. Mathot, R.A.A. Quaedackers, M.E. Vulto, A.G. Weimar, W. Gelder, T. van
|
2009-10-01
|
Interpatient variability in IMPDH activity in MMF-treated renal transplant patients is correlated with IMPDH type II 3757T>C polymorphism
(Article)
Sombogaard, F. Schaik, R.H.N. van Mathot, R.A. Budde, K. Werf, M. van der Vulto, A.G. Weimar, W. Glander, P. Essioux, L. Gelder, T. van
|
2009-08-01
|
Improved assay for the nonradioactive determination of inosine 5'-monophosphate dehydrogenase activity in peripheral blood mononuclear cells
(Article)
Glander, P. Sombogaard, F. Mathot, R.A. Budde, K. Gelder, T. van Hambach, P. Liefeldt, L. Lorkowski, C. Mai, M. Neumayer, H.H. Vulto, A.G.
|
2009-06-01
|